Genes
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
85,013 comparisons from ClinicalTrials.gov.
Most participants first33,758 with no events in either group come last3,081 to 3,100 of 85,013
| Comparison | With the outcome | Risk difference, 95% interval | Participants | Trial |
|---|---|---|---|---|
| Absorb BVS vs XIENCE: Number of Participants With All Coronary Revascularization | 198 of 1,189 167 of 1,200 | 2.7 points -0.2 to 5.6 | 2,389 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants With Myocardial Infarction (MI) | 154 of 1,189 134 of 1,200 | 1.8 points -0.8 to 4.4 | 2,389 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Absorb BVS vs XIENCE: Number of Participants Experienced Cardiac Death/TV-MI/ID-TLR (TLF) | 216 of 1,189 180 of 1,200 | 3.2 points 0.2 to 6.1 | 2,389 | NCT02173379 Absorb IV Randomized Controlled Trial |
| Static Frequency vs Dynamic Frequency: Hospitalizations | 310 of 1,069 444 of 1,320 | -4.6 points -8.3 to -0.9 | 2,389 | NCT05225298 SARS-COV-2 Screening in Dialysis Facilities |
| Static Frequency vs Dynamic Frequency: deaths from any cause | 31 of 1,069 41 of 1,320 | -0.2 points -1.6 to 1.2 | 2,389 | NCT05225298 SARS-COV-2 Screening in Dialysis Facilities |
| Static Frequency vs Dynamic Frequency: Deaths | 31 of 1,069 41 of 1,320 | -0.2 points -1.6 to 1.2 | 2,389 | NCT05225298 SARS-COV-2 Screening in Dialysis Facilities |
| Folic Acid and Zinc Supplementation vs Placebo: Preeclampsia or Gestational Hypertension | 47 of 1,185 51 of 1,185 | -0.3 points -2.0 to 1.3 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
| Folic Acid and Zinc Supplementation vs Placebo: Early Pregnancy Loss | 137 of 1,185 150 of 1,185 | -1.1 points -3.7 to 1.5 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
| Folic Acid and Zinc Supplementation vs Placebo: Human Chorionic Gonadotropin (hCG) Detected Pregnancy (Implantation) | 479 of 1,185 490 of 1,185 | -0.9 points -4.9 to 3.0 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
| Folic Acid and Zinc Supplementation vs Placebo: Neonatal Mortality | 3 of 1,185 2 of 1,185 | 0.1 points -0.4 to 0.6 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
| Folic Acid and Zinc Supplementation vs Placebo: Gestational Diabetes | 26 of 1,185 34 of 1,185 | -0.7 points -2.0 to 0.6 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
| Folic Acid and Zinc Supplementation vs Placebo: Small for Gestational Age | 62 of 1,185 59 of 1,185 | 0.3 points -1.5 to 2.0 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
| Folic Acid and Zinc Supplementation vs Placebo: Preterm Delivery | 67 of 1,185 45 of 1,185 | 1.9 points 0.1 to 3.6 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
| Folic Acid and Zinc Supplementation vs Placebo: Severe Maternal Morbidity | 15 of 1,185 10 of 1,185 | 0.4 points -0.4 to 1.3 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
| Folic Acid and Zinc Supplementation vs Placebo: Ectopic Pregnancy | 6 of 1,185 5 of 1,185 | 0.1 points -0.5 to 0.7 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
| Folic Acid and Zinc Supplementation vs Placebo: Stillbirth | 1 of 1,185 4 of 1,185 | -0.3 points -0.8 to 0.2 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
| Folic Acid and Zinc Supplementation vs Placebo: Structural Malformations | 15 of 1,185 14 of 1,185 | 0.1 points -0.9 to 1.0 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
| Folic Acid and Zinc Supplementation vs Placebo: Clinical Intrauterine Pregnancy | 449 of 1,185 462 of 1,185 | -1.1 points -5.0 to 2.8 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
| Folic Acid and Zinc Supplementation vs Placebo: Cesarean Delivery | 143 of 1,185 129 of 1,185 | 1.2 points -1.4 to 3.8 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
| Folic Acid and Zinc Supplementation vs Placebo: Major Neonatal Complications | 2 of 1,185 1 of 1,185 | 0.1 points -0.3 to 0.5 | 2,370 | NCT01857310 Folic Acid and Zinc Supplementation Trial (FAZST) |
Code
curl "https://conductscience.org/api/comparisons/v1?page=155"
Response
The first 2 of this page's 20 results. GET /api/comparisons/v1?page=155
{
"data": {
"total": 85013,
"results": [
{
"id": "NCT02173379-aa729106",
"title": "Absorb BVS vs XIENCE: Number of Participants With All Coronary Revascularization",
"summary": "198 of 1189 against 167 of 1200; risk difference 2.7 points, 95% interval -0.2 to 5.6; NCT02173379, Absorb IV Randomized Controlled Trial",
"record": "/library/comparisons/NCT02173379-aa729106",
"nct_id": "NCT02173379",
"kind": "outcome",
"participants": 2389,
"risk_difference": {
"value": 0.02735982618446875,
"lower": -0.0015166884804299306,
"upper": 0.05624898658750779
},
"group_1": "198 of 1,189",
"group_2": "167 of 1,200",
"difference": "2.7 points",
"interval": "-0.2 to 5.6",
"trial_title": "Absorb IV Randomized Controlled Trial"
},
{
"id": "NCT02173379-bfd07f89",
"title": "Absorb BVS vs XIENCE: Number of Participants With Myocardial Infarction (MI)",
"summary": "154 of 1189 against 134 of 1200; risk difference 1.8 points, 95% interval -0.8 to 4.4; NCT02173379, Absorb IV Randomized Controlled Trial",
"record": "/library/comparisons/NCT02173379-bfd07f89",
"nct_id": "NCT02173379",
"kind": "outcome",
"participants": 2389,
"risk_difference": {
"value": 0.017853938884216436,
"lower": -0.008303012932955385,
"upper": 0.04406273545453761
},
"group_1": "154 of 1,189",
"group_2": "134 of 1,200",
"difference": "1.8 points",
"interval": "-0.8 to 4.4",
"trial_title": "Absorb IV Randomized Controlled Trial"
}
],
"no_events": 33758,
"columns": [
{
"key": "title",
"label": "Comparison"
},
{
"key": "group_1",
"label": "With the outcome",
"under": "group_2"
},
{
"key": "difference",
"label": "Risk difference, 95% interval",
"under": "interval"
},
{
"key": "participants",
"label": "Participants"
},
{
"key": "nct_id",
"label": "Trial",
"under": "trial_title"
}
],
"order": "Most participants first",
"kinds": {
"all": 85013,
"outcome": 33568,
"serious-adverse-events": 31897,
"deaths": 19548
}
},
"release": "trial-comparisons-2026-03-23-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "No license stated"
}
],
"next": "/api/comparisons/v1?page=156",
"request_id": "so76S2zjwIITuTVR"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/comparisons/v1. No key.
GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome
Ask an assistant